Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,078.00p
   
  • Change Today:
      24.00p
  • 52 Week High: 1,208.50
  • 52 Week Low: 917.60
  • Currency: UK Pounds
  • Shares Issued: 875.94m
  • Volume: 1,955,375
  • Market Cap: £9,443m
  • RiskGrade: 173

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart (01-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.6% 0.0%
Div Cover 2.2 2.6
Op Mrgn 11.3% 17.3%
ROCE 13.3%  
Latest F'cast
P/E 17.0 12.6
PEG 9.4 n/a
Pr/Revenue 2.2 1.4
Pr/Book 2.4  
Latest F'cast
Revenue 4.7% -21.6%
PBT 71.7% 58.1%
EPS 1.8% -7.5%
DPS n/a -39.8%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 4,560.00 246.00 64.60¢ 31.1 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 21.3 0.9 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 18.1 18.1 +1% 37.50¢ 2.5%
31-Dec-23 5,549.00 290.00 82.80¢ 17.3 17.3 +1% 37.50¢ 2.6%
31-Dec-24 5,810.00 498.00 84.30¢ 15.7 7.8 +2% 37.50¢ 2.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 6,060.21 1,047.55 77.96p 13.8 n/a -8% 30.04p 0.0%
31-Dec-26 6,369.56 1,167.50 88.21p 12.2 0.9 +13% 33.10p 0.0%
31-Dec-27 6,688.24 1,281.26 91.66p 11.8 3.0 +4% 34.88p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Total Voting Rights 01-May-2025 11:27 RNS
Result of AGM 30-Apr-2025 17:30 RNS
Smith+Nephew First Quarter 2025 Trading Update 30-Apr-2025 07:00 RNS

Smith and Nephew ShareCast News

London close: Stocks finish higher as US economy... 30-Apr-2025 ShareCast
Smith & Nephew reiterates full-year outlook desp... 30-Apr-2025 ShareCast
Smith & Nephew shares lift as profits, sales bea... 25-Feb-2025 ShareCast

Smith and Nephew Top Newspaper Links

Smith & Nephew boosted by orthopaedics sales ami... 01-May-2025 Times
Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph

Latest Smith and Nephew Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,078.00p
Change Today 24.00p
% Change 2.28 %
52 Week High 1,208.50
52 Week Low 917.60
Volume 1,955,375
Shares Issued 875.94m
Market Cap £9,443m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average
Price Trend
45.01% above the market average45.01% above the market average45.01% above the market average45.01% above the market average45.01% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average
Income
39.32% below the market average39.32% below the market average39.32% below the market average39.32% below the market average39.32% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
0.86% above the market average0.86% above the market average0.86% above the market average0.86% above the market average0.86% above the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 11
Sell 0
Strong Sell 0
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 27-Mar-25 03-Oct-24
Paid 28-May-25 08-Nov-24
Amount 23.10¢ 14.40¢

Trades for 01-May-2025

Time Volume / Share Price
16:36 7,193 @ 1,078.00p
16:36 417 @ 1,078.00p
16:36 2,390 @ 1,078.00p
16:36 1 @ 1,078.00p
16:36 741 @ 1,078.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page